Jersey lawyers advise on blood transfusion deal

Friday 28 October 2016

A Jersey legal firm has played a key role in a business deal that could transform the blood transfusion diagnostic market.

Bedell Cristin, led by partner Alasdair Hunter, advised Morgan Stanley with the issue by Quotient Limited of US$120m fixed rate senior secured loan notes due 2023 and the related security package.

Quotient, a Jersey incorporated company listed on NASDAQ, is a diagnostics company committed to reducing healthcare costs and improving patient care through the provision of innovate tests within established markets.

At the initial closing, Quotient issued US$84m of Notes with an additional US$36m of Notes to be issued upon public announcement of field trial results for MosaiQ, a next generation automation platform which it's claimed could transform the US$2.8bn blood transfusion diagnostics market.